International Flavors & Fragrances Health & Biosciences — Foreign exchange decreased by 540.0% to -$22.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 136.7%, from $60.00M to -$22.00M. Over 2 years (FY 2023 to FY 2025), Health & Biosciences — Foreign exchange shows an upward trend with a 84.7% CAGR.
Large fluctuations indicate high exposure to international currency volatility, which can obscure underlying operational performance.
The impact of currency fluctuations on the financial results of the Health & Biosciences segment, resulting from operati...
Commonly reported as 'FX impact' or 'Currency translation' by multinational corporations.
iff_segment_health_biosciences_foreign_exchange| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$63.00M | -$39.00M | -$42.00M | -$137.00M | -$161.00M | $32.00M | $27.00M | -$66.00M | $63.00M | -$39.00M | -$10.00M | $69.00M | -$116.00M | $60.00M | $126.00M | $0.00 | $5.00M | -$22.00M |
| QoQ Change | — | +38.1% | -7.7% | -226.2% | -17.5% | +119.9% | -15.6% | -344.4% | +195.5% | -161.9% | +74.4% | +790.0% | -268.1% | +151.7% | +110.0% | -100.0% | — | -540.0% |
| YoY Change | — | — | — | — | -155.6% | +176.2% | +119.7% | +59.0% | — | -221.9% | -137.0% | +204.5% | -284.1% | +253.8% | >999% | -100.0% | +104.3% | -136.7% |